Stay updated on Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded revision v3.5.0 to the record history. Removed revision v3.4.3 from the record history.SummaryDifference0.1%

- Check23 days agoChange DetectedAdded Revision: v3.4.3 to the Record History and removed Revision: v3.4.2.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry, v3.4.2, was added to the record history, and the government funding notice banner was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check59 days agoChange DetectedThe history page now includes a government funding notice and a new revision tag (v3.4.1) while the prior revision (v3.4.0) is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check66 days agoChange DetectedUI updates include a 'Show glossary' option, visible color-coded highlights for additions and deletions, and a new revision tag 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check80 days agoChange DetectedNew revision v3.3.4 was added to the study record history, and revision v3.3.3 was removed, reflecting a minor update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.